Working to Eradicate Gynecologic Cancers

Seminal Abstract Session

Sunday, March 29, 2015: 11:00 AM-12:15 PM
International Ballroom (Hilton Chicago)
Description: In this session, seminal international trials and their updates will be presented. These landmark studies cross a spectrum of gynecologic malignancies, and include trials for the prevention and treatment of gynecologic cancers.
Moderators:  Ginger J. Gardner, MD, Memorial Sloan Kettering Cancer Center, New York, NY and Marcela del Carmen, MD, MPH, Massachusetts General Hospital, Boston, MA
11:00 AM
Introductory Remarks
G. J. Gardner1 and M. G. Del Carmen2
1Memorial Sloan Kettering Cancer Center, New York, NY, 2Massachusetts General Hospital/Harvard University, Boston, MA
 
11:05 AM
(1) GCaPPS study (population testing for BRCA1/2 mutations) (2) Data on screening performance in UKCTOCS and UKFOCSS
I. Jacobs
University of Manchester, Manchester, United Kingdom
 
11:27 AM
Q&A 1
 
11:33 AM
Uterine Transplantation (UTx) as an infertility treatment for absolute uterine-factor infertility including cervical cancer
P. Dahm-Kahler
University of Gothenburg, Gothenburg, Sweden
 
11:44 AM
Q&A 2
 
11:47 AM
Efficacy of the 9-valent HPV vaccine: End of study data
E. Joura
Medical university of Vienna, Vienna, Austria
 
11:58 AM
Q & A 3
 
12:01 PM
RANDOMIZED PHASE 2 EVALUATION OF BEVACIZUMAB VERSUS BEVACIZUMAB/FOSBRETABULIN IN RECURRENT OVARIAN, TUBAL OR PERITONEAL CARCINOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY
B. J. Monk
University of Arizona Cancer Center, Phoenix, AZ
 
12:12 PM
Q & A 4
 
12:15 PM
Moderator
G. J. Gardner
Memorial Sloan Kettering Cancer Center, New York, NY
 
12:15 PM
Moderator
M. del Carmen
Massachusetts General Hospital, Boston, MA
 
See more of: Seminal Session
<< Previous Course | Next Course >>